Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice
Abstract. Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst developm
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
29 January 2016
|
| In: |
Nephrology, dialysis, transplantation
Year: 2016, Volume: 31, Issue: 3, Pages: 337-348 |
| ISSN: | 1460-2385 |
| DOI: | 10.1093/ndt/gfv456 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1093/ndt/gfv456 Verlag, Volltext: https://academic.oup.com/ndt/article/31/3/337/2460159 
|
| Author Notes: | Ron T. Gansevoort, Mustafa Arici, Thomas Benzing, Henrik Birn, Giovambattista Capasso, Adrian Covic, Olivier Devuyst, Christiane Drechsler, Kai-Uwe Eckardt, Francesco Emma, Bertrand Knebelmann, Yannick Le Meur, Ziad A. Massy, Albert C. M. Ong, Alberto Ortiz, Franz Schaefer, Roser Torra, Raymond Vanholder, Andrzej Więcek, Carmine Zoccali and Wim Van Biesen |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1692282182 | ||
| 003 | DE-627 | ||
| 005 | 20220818012040.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200311s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ndt/gfv456 |2 doi | |
| 035 | |a (DE-627)1692282182 | ||
| 035 | |a (DE-599)KXP1692282182 | ||
| 035 | |a (OCoLC)1341310197 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Gansevoort, Ron T. |e VerfasserIn |0 (DE-588)1206290706 |0 (DE-627)1692281933 |4 aut | |
| 245 | 1 | 0 | |a Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease |b a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice |c Ron T. Gansevoort, Mustafa Arici, Thomas Benzing, Henrik Birn, Giovambattista Capasso, Adrian Covic, Olivier Devuyst, Christiane Drechsler, Kai-Uwe Eckardt, Francesco Emma, Bertrand Knebelmann, Yannick Le Meur, Ziad A. Massy, Albert C. M. Ong, Alberto Ortiz, Franz Schaefer, Roser Torra, Raymond Vanholder, Andrzej Więcek, Carmine Zoccali and Wim Van Biesen |
| 264 | 1 | |c 29 January 2016 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.03.2020 | ||
| 520 | |a Abstract. Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst developm | ||
| 700 | 1 | |a Arici, Mustafa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Benzing, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Birn, Henrik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Capasso, Giovambattista |e VerfasserIn |4 aut | |
| 700 | 1 | |a Covic, Adrian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Devuyst, Olivier |e VerfasserIn |4 aut | |
| 700 | 1 | |a Drechsler, Christiane |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eckardt, Kai-Uwe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Emma, Francesco |e VerfasserIn |4 aut | |
| 700 | 1 | |a Knebelmann, Bertrand |e VerfasserIn |4 aut | |
| 700 | 1 | |a Le Meur, Yannick |e VerfasserIn |4 aut | |
| 700 | 1 | |a Massy, Ziad A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ong, Albert C. M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ortiz, Alberto |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schaefer, Franz |d 1961- |e VerfasserIn |0 (DE-588)1023365383 |0 (DE-627)718365577 |0 (DE-576)366705598 |4 aut | |
| 700 | 1 | |a Torra, Roser |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vanholder, Raymond |e VerfasserIn |4 aut | |
| 700 | 1 | |a Więcek, Andrzej |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zoccali, Carmine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Van Biesen, Wim |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nephrology, dialysis, transplantation |d Oxford : Oxford Univ. Press, 1986 |g 31(2016), 3, Seite 337-348 |h Online-Ressource |w (DE-627)265778395 |w (DE-600)1465709-0 |w (DE-576)079420079 |x 1460-2385 |7 nnas |a Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice |
| 773 | 1 | 8 | |g volume:31 |g year:2016 |g number:3 |g pages:337-348 |g extent:12 |a Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice |
| 856 | 4 | 0 | |u https://doi.org/10.1093/ndt/gfv456 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/ndt/article/31/3/337/2460159 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200311 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1023365383 |a Schaefer, Franz |m 1023365383:Schaefer, Franz |d 910000 |d 910500 |e 910000PS1023365383 |e 910500PS1023365383 |k 0/910000/ |k 1/910000/910500/ |p 16 | ||
| 999 | |a KXP-PPN1692282182 |e 3606523246 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1692282182","id":{"eki":["1692282182"],"doi":["10.1093/ndt/gfv456"]},"physDesc":[{"extent":"12 S."}],"language":["eng"],"relHost":[{"id":{"issn":["1460-2385"],"zdb":["1465709-0"],"eki":["265778395"]},"recId":"265778395","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 01-04-14"],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"337-348","extent":"12","issue":"3","volume":"31","year":"2016","text":"31(2016), 3, Seite 337-348"},"pubHistory":["1.1986 -"],"origin":[{"publisher":"Oxford Univ. Press","dateIssuedKey":"1986","dateIssuedDisp":"1986-","publisherPlace":"Oxford"}],"titleAlt":[{"title":"Nephrology, dialysis, transplantation online"}],"title":[{"title":"Nephrology, dialysis, transplantation","title_sort":"Nephrology, dialysis, transplantation"}],"disp":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeNephrology, dialysis, transplantation"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 11.03.2020"],"origin":[{"dateIssuedDisp":"29 January 2016","dateIssuedKey":"2016"}],"name":{"displayForm":["Ron T. Gansevoort, Mustafa Arici, Thomas Benzing, Henrik Birn, Giovambattista Capasso, Adrian Covic, Olivier Devuyst, Christiane Drechsler, Kai-Uwe Eckardt, Francesco Emma, Bertrand Knebelmann, Yannick Le Meur, Ziad A. Massy, Albert C. M. Ong, Alberto Ortiz, Franz Schaefer, Roser Torra, Raymond Vanholder, Andrzej Więcek, Carmine Zoccali and Wim Van Biesen"]},"title":[{"title_sort":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease","title":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease","subtitle":"a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice"}],"person":[{"given":"Ron T.","display":"Gansevoort, Ron T.","role":"aut","roleDisplay":"VerfasserIn","family":"Gansevoort"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Arici","display":"Arici, Mustafa","given":"Mustafa"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Benzing","given":"Thomas","display":"Benzing, Thomas"},{"given":"Henrik","display":"Birn, Henrik","family":"Birn","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Giovambattista","display":"Capasso, Giovambattista","family":"Capasso","role":"aut","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Covic","display":"Covic, Adrian","given":"Adrian"},{"display":"Devuyst, Olivier","given":"Olivier","role":"aut","roleDisplay":"VerfasserIn","family":"Devuyst"},{"given":"Christiane","display":"Drechsler, Christiane","family":"Drechsler","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Eckardt","roleDisplay":"VerfasserIn","role":"aut","display":"Eckardt, Kai-Uwe","given":"Kai-Uwe"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Emma","display":"Emma, Francesco","given":"Francesco"},{"display":"Knebelmann, Bertrand","given":"Bertrand","role":"aut","roleDisplay":"VerfasserIn","family":"Knebelmann"},{"display":"Le Meur, Yannick","given":"Yannick","role":"aut","roleDisplay":"VerfasserIn","family":"Le Meur"},{"family":"Massy","roleDisplay":"VerfasserIn","role":"aut","display":"Massy, Ziad A.","given":"Ziad A."},{"family":"Ong","roleDisplay":"VerfasserIn","role":"aut","display":"Ong, Albert C. M.","given":"Albert C. M."},{"roleDisplay":"VerfasserIn","role":"aut","family":"Ortiz","given":"Alberto","display":"Ortiz, Alberto"},{"given":"Franz","display":"Schaefer, Franz","family":"Schaefer","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Roser","display":"Torra, Roser","role":"aut","roleDisplay":"VerfasserIn","family":"Torra"},{"family":"Vanholder","role":"aut","roleDisplay":"VerfasserIn","display":"Vanholder, Raymond","given":"Raymond"},{"given":"Andrzej","display":"Więcek, Andrzej","family":"Więcek","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Zoccali, Carmine","given":"Carmine","role":"aut","roleDisplay":"VerfasserIn","family":"Zoccali"},{"given":"Wim","display":"Van Biesen, Wim","family":"Van Biesen","roleDisplay":"VerfasserIn","role":"aut"}]} | ||
| SRT | |a GANSEVOORTRECOMMENDA2920 | ||